Common Contracts
2 similar Patent and Technology Assignment Agreement contracts by RXi Pharmaceuticals Corp
ContractPatent and Technology Assignment Agreement • May 5th, 2020 • Massachusetts
EX-10.5 7 b88518exv10w5.htm EX-10.5 Exhibit 10.5 PATENT AND TECHNOLOGY ASSIGNMENT AGREEMENT This Patent and Technology Assignment Agreement (“AGREEMENT”), is by and between ADVIRNA, LLC, a Colorado limited liability company having its principal place of business at 10 Rocklawn Road, Westborough, MA 01581 (“ADVIRNA”) and RXi Pharmaceuticals Corporation (formerly RNCS, Inc.), a Delaware corporation, having its principal place of business at 60 Prescott Street, Worcester, MA 01605 (“RXi”). ADVIRNA and RXi may each be referred to as a “PARTY” and collectively as the “PARTIES”. For good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the PARTIES agree as follows: 1.0 Background of Agreement 1.1 ADVIRNA owns certain PATENT RIGHTS and TECHNOLOGY RIGHTS. 1.2 ADVIRNA desires to assign, transfer and convey to RXi, all right, title and interest in and to selected PATENT RIGHTS and TECHNOLOGY RIGHTS of ADVIRNA and RXI desires to develop, sell and distribute pr
PATENT AND TECHNOLOGY ASSIGNMENT AGREEMENTPatent and Technology Assignment Agreement • October 25th, 2011 • RXi Pharmaceuticals Corp • Massachusetts
This Patent and Technology Assignment Agreement (“AGREEMENT”), is by and between ADVIRNA, LLC, a Colorado limited liability company having its principal place of business at 10 Rocklawn Road, Westborough, MA 01581 (“ADVIRNA”) and RXi Pharmaceuticals Corporation (formerly RNCS, Inc.), a Delaware corporation, having its principal place of business at 60 Prescott Street, Worcester, MA 01605 (“RXi”). ADVIRNA and RXi may each be referred to as a “PARTY” and collectively as the “PARTIES”. For good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the PARTIES agree as follows:
